Therapy with cholesteryl ester transfer protein (CETP) inhibitors and diabetes risk-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Therapy with cholesteryl ester transfer protein (CETP) inhibitors and diabetes risk

Published:2018-12 Issue:6 Volume:44 Page:508-513
ISSN:1262-3636
Container-title:Diabetes & Metabolism
language:en
Short-container-title:Diabetes & Metabolism

Author:

Masson W.,Lobo M.,Siniawski D.,Huerín M.,Molinero G.,Valéro R.,Nogueira J.P.

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference40 articles.

1. Heart disease and stroke statistics-2016 update: a report from the American Heart Association;Mozaffarian;Circulation,2016

2. Statins and risk of incident diabetes: a collaborative meta-analysis of randomized statin trials;Sattar;Lancet,2010

3. Cholesteryl ester transfer protein inhibitors: challenges and perspectives;Filippatos;Expert Rev Cardiovasc Ther,2016

4. Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk;Barter;J Lipid Res,2012

5. Effects of torcetrapib in patients at high risk for coronary events;Barter;N Engl J Med,2007

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Obicetrapib on top of maximally tolerated lipid‐modifying therapies in participants with or at high risk for atherosclerotic cardiovascular disease: rationale and designs of BROADWAY and BROOKLYN;American Heart Journal;2024-08

2. Insights into the metabolic consequences of type 2 diabetes;2024-06-25

3. CETP and SGLT2 inhibitor combination therapy increases glycemic control: a 2x2 factorial Mendelian randomization analysis;Frontiers in Endocrinology;2024-06-19

4. Synthesis and In-Silico Studies of Ortho-Fluorinated Benzenesulfonamides as Putative Anti-CETP Agents;Current Organic Chemistry;2024-05

5. Hyperlipidaemia in diabetes: are there particular considerations for next-generation therapies?;Diabetologia;2024-02-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3